These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 28078633)
1. Benzodiazepine Use and Risk of Developing Alzheimer's Disease: A Case-Control Study Based on Swiss Claims Data. Biétry FA; Pfeil AM; Reich O; Schwenkglenks M; Meier CR CNS Drugs; 2017 Mar; 31(3):245-251. PubMed ID: 28078633 [TBL] [Abstract][Full Text] [Related]
2. Benzodiazepine Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis. Imfeld P; Bodmer M; Jick SS; Meier CR Drug Saf; 2015 Oct; 38(10):909-19. PubMed ID: 26123874 [TBL] [Abstract][Full Text] [Related]
3. The risk of Alzheimer's disease associated with benzodiazepines and related drugs: a nested case-control study. Tapiainen V; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen AM Acta Psychiatr Scand; 2018 Aug; 138(2):91-100. PubMed ID: 29851063 [TBL] [Abstract][Full Text] [Related]
4. The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease. Saarelainen L; Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S J Alzheimers Dis; 2016; 49(3):809-18. PubMed ID: 26484930 [TBL] [Abstract][Full Text] [Related]
5. Risk of death associated with new benzodiazepine use among persons with Alzheimer disease: A matched cohort study. Saarelainen L; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H Int J Geriatr Psychiatry; 2018 Apr; 33(4):583-590. PubMed ID: 29143367 [TBL] [Abstract][Full Text] [Related]
6. Risk of Hip Fracture in Benzodiazepine Users With and Without Alzheimer Disease. Saarelainen L; Tolppanen AM; Koponen M; Tanskanen A; Sund R; Tiihonen J; Hartikainen S; Taipale H J Am Med Dir Assoc; 2017 Jan; 18(1):87.e15-87.e21. PubMed ID: 27847263 [TBL] [Abstract][Full Text] [Related]
7. The Use of Benzodiazepine Receptor Agonists and Risk of Respiratory Failure in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Case-Control Study. Chen SJ; Yeh CM; Chao TF; Liu CJ; Wang KL; Chen TJ; Chou P; Wang FD Sleep; 2015 Jul; 38(7):1045-50. PubMed ID: 25669186 [TBL] [Abstract][Full Text] [Related]
8. Benzodiazepine use and risk of Alzheimer's disease: case-control study. Billioti de Gage S; Moride Y; Ducruet T; Kurth T; Verdoux H; Tournier M; Pariente A; Bégaud B BMJ; 2014 Sep; 349():g5205. PubMed ID: 25208536 [TBL] [Abstract][Full Text] [Related]
9. Statin use and risk of cholecystectomy - A case-control analysis using Swiss claims data. Biétry FA; Reich O; Schwenkglenks M; Meier CR Expert Opin Drug Saf; 2016 Dec; 15(12):1577-1582. PubMed ID: 27677561 [TBL] [Abstract][Full Text] [Related]
10. Association Between Incident Exposure to Benzodiazepines in Early Pregnancy and Risk of Spontaneous Abortion. Sheehy O; Zhao JP; Bérard A JAMA Psychiatry; 2019 Sep; 76(9):948-957. PubMed ID: 31090881 [TBL] [Abstract][Full Text] [Related]
11. Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study. Gray SL; Dublin S; Yu O; Walker R; Anderson M; Hubbard RA; Crane PK; Larson EB BMJ; 2016 Feb; 352():i90. PubMed ID: 26837813 [TBL] [Abstract][Full Text] [Related]
12. Proton Pump Inhibitor Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis. Imfeld P; Bodmer M; Jick SS; Meier CR Drug Saf; 2018 Dec; 41(12):1387-1396. PubMed ID: 30146658 [TBL] [Abstract][Full Text] [Related]
13. Acetylcholinesterase inhibitors and the risk of hip fracture in Alzheimer's disease patients: a case-control study. Tamimi I; Ojea T; Sanchez-Siles JM; Rojas F; Martin I; Gormaz I; Perez A; Dawid-Milner MS; Mendez L; Tamimi F J Bone Miner Res; 2012 Jul; 27(7):1518-27. PubMed ID: 22467182 [TBL] [Abstract][Full Text] [Related]
14. Use of Anti-Dementia Drugs in Relation to Change in Cognition, Behavior, and Functioning in Alzheimer's Disease over a Three-Year Period: Kuopio ALSOVA Study. Törmälehto SM; Martikainen JA; Väätäinen ST; Hallikainen IT; Hallikainen M; Bell JS; Koivisto AM J Alzheimers Dis; 2015; 48(4):1033-41. PubMed ID: 26444756 [TBL] [Abstract][Full Text] [Related]
15. Use of selective serotonin reuptake inhibitors, other antidepressant medication, and risk of cataract: a case-control study based on Swiss claims data. Becker C; Schwenkglenks M; Frueh M; Reich O; Meier CR Eur J Clin Pharmacol; 2020 Sep; 76(9):1329-1335. PubMed ID: 32504184 [TBL] [Abstract][Full Text] [Related]
16. Diabetes mellitus and risk of early-onset Alzheimer's disease: a population-based case-control study. Kadohara K; Sato I; Kawakami K Eur J Neurol; 2017 Jul; 24(7):944-949. PubMed ID: 28503814 [TBL] [Abstract][Full Text] [Related]
17. Drug use in persons with and without Alzheimer's disease aged 90 years or more. Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S Age Ageing; 2016 Nov; 45(6):900-904. PubMed ID: 27609205 [TBL] [Abstract][Full Text] [Related]
18. Predictors of adherence among Alzheimer's disease patients receiving oral therapy. Borah B; Sacco P; Zarotsky V Curr Med Res Opin; 2010 Aug; 26(8):1957-65. PubMed ID: 20569067 [TBL] [Abstract][Full Text] [Related]
19. Use of antidepressants among community-dwelling persons with Alzheimer's disease: a nationwide register-based study. Laitinen ML; Lönnroos E; Bell JS; Lavikainen P; Sulkava R; Hartikainen S Int Psychogeriatr; 2015 Apr; 27(4):669-72. PubMed ID: 25412711 [TBL] [Abstract][Full Text] [Related]
20. Regular Benzodiazepine and Z-Substance Use and Risk of Dementia: An Analysis of German Claims Data. Gomm W; von Holt K; Thomé F; Broich K; Maier W; Weckbecker K; Fink A; Doblhammer G; Haenisch B J Alzheimers Dis; 2016 Sep; 54(2):801-8. PubMed ID: 27567804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]